ACH-2928

5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Sat, 04/21/12 - 12:17 pm
Vertex
Incivek
ABT-072
ABT-450
Abbott Laboratories
Achillion
ACH-1625
ACH-2684
ACH-2928
ACH-3102
TMC435
JNJ
GSK
hepatitis C
Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C
Yahoo/Globe NewsWire
Sat, 04/21/12 - 12:05 pm
Achillion
ACH-1625
ACH-3102
ACH-2928
hepatitis C
Achillion: A Compelling 'Buy' Candidate Now
Motley Fool
Mon, 04/16/12 - 11:51 am
Achillion
ACH-1625
ACH-2684
ACH-2928